Saturday November 21 2009 | Biotechnology feed | All feeds
|
|
|
Reportlinker Adds Chinese Markets for Brain Cancer Treatment DrugsTuesday 3rd of November 2009 11:04NEW YORK, Nov. 3 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Chinese Markets for Brain Cancer Treatment Drugs China's demand for Brain Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-term forecasts through 2013 and 2018 are presented. Major producers in China are profiled. TABLE OF CONTENTS I. INTRODUCTION Report Scope and Methodology Executive Summary II. BUSINESS ENVIRONMENT Economic Outlook Key Economic Indicators Industrial Output Population and Labor Foreign Investment Foreign Trade Financial and Tax Regulations Banking System and Regulations Foreign Exchange Taxes, Tariff and Custom Duties III. BRAIN CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS Brain Cancer Treatment Drugs Industry Structure Market Size Market Growth Driver Brain Cancer Treatment Drugs Sales Volume Major Producer Facility Locations Major Producers Sales Volume and Market Share Labor Cost Potential Entrants Major Distributors Major Foreign Investments Technology Development IV. BRAIN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND Overviews Sales Volume of Brain Cancer Treatment Drugs by Region Brain Cancer Treatment Drugs Sales Volume Cytotoxic Drugs Sales Volume Alkylating Agents Antimetabolites Anti-Tumor Antibiotics Hormones Mitotic Inhibitors Steroids Cytostatic Drugs Sales Volume Drugs Aimed at Reducing Drug Resistance Anti-Angiogenesis Inhibitors Growth Factor Inhibitors Brain Cancer Treatment Drugs Imports and Exports Pricing Trends V. CHINA BRAIN CANCER TREATMENT DRUGS MARKET OUTLOOK Brain Cancer Treatment Drugs Markets Outlook Overview Government Regulations Health Care Insurance Industry Overview Consumer Spending Trends Demographic Trends Health Care Industry Trends Hospitals and Hospital Beds Physicians and Physician Visits VI. MARKETING STRATEGIES China Market Entry Overview China's Distribution System Brain Cancer Treatment Drugs Distribution Channels Transportation and Freight Infrastructure Communications China's Market Entry Export to China Indirect export Direct Export License and Contract Manufacture Assembling in China Contract Manufacturing Trade Permit Investment Equity Joint Venture Contractual Joint Venture Wholly Foreign-Owned Enterprise VII. BRAIN CANCER TREATMENT DRUGS PRODUCER DIRECTORY Brain Cancer Treatment Drugs Producer Profiles and Directory Major End-Users LIST OF TABLES I. INTRODUCTION Economic Outlook Summary II. BUSINESS ENVIRONMENT Key Economic Indicators Industrial Output Population and Labor Force Trends Foreign Investment and Loans Foreign Trade III. BRAIN CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS Brain Cancer Treatment Drugs Sales Volume and Market Share by Drugs Classification in 2008 Brain Cancer Treatment Drugs Sales Volume Major Producer Facility Location Major Brain Cancer Treatment Drugs Producer Sales Volume Major Foreign Investment in China IV. BRAIN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND Brain Cancer Treatment Drugs Sales Volume Demand of Brain Cancer Treatment Drugs by Region in 2008 Alkylating Agents Sales Volume Alkylating Agents Major Producer and Their Market Share in 2008 Antimetabolites Sales Volume Antimetabolites Major Producer and Their Market Share in 2008 Anti-Tumor Antibiotics Sales Volume Anti-Tumor Antibiotics Major Producer and Their Market Share in 2008 Hormones Sales Volume Hormones Major Producer and Their Market Share in 2008 Mitotic Inhibitors Sales Volume Mitotic Inhibitors Major Producer and Their Market Share in 2008 Steroids Sales Volume Steroids Major Producer and Their Market Share in 2008 Drugs Aimed at Reducing Drug Resistance Sales Volume Drugs Aimed at Reducing Drug Resistance Major Producer and Their Market Share in 2008 Anti-Angiogenesis Inhibitors Sales Volume Anti-Angiogenesis Inhibitors Major Producer and Their Market Share in 2008 Growth Factor Inhibitors Sales Volume Growth Factor Inhibitors Major Producer and Their Market Share China's Brain Cancer Treatment Drugs Imports and Exports V. BRAIN CANCER TREATMENT DRUGS MARKET OUTLOOK Brain Cancer Treatment Drugs Sales Volume Consumer Spending Trends Demographic Trends Health Care Industry Trends Hospitals and Hospital Beds Physicians and Physician Visits LIST OF CHARTS I. INTRODUCTION China's Brain Cancer Treatment Drugs Sales Volume II. BUSINESS ENVIRONMENT China's GDP and Growth Rate Specialty Output by Ownership China's Imports and Exports III. BRAIN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND Brain Cancer Treatment Drugs Sales Volume by Drugs Classification in 2008 Brain Cancer Treatment Drugs Sales Volume IV. BRAIN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND Brain Cancer Treatment Drugs Sales Volume in China Brain Cancer Treatment Drugs Sales Volume by Type Alkylating Agents Sales Volume Antimetabolites Sales Volume Anti-Tumor Antibiotics Sales Volume Hormones Sales Volume Mitotic Inhibitors Sales Volume Steroids Sales Volume Drugs Aimed at Reducing Drug Resistance Sales Volume Anti-Angiogenesis Inhibitors Sales Volume Growth Factor Inhibitors Sales Volume Total Brain Cancer Treatment Drugs Import and Export V. BRAIN CANCER TREATMENT DRUGS MARKET OUTLOOK Brain Cancer Treatment Drugs Sales Volume VI. MARKETING STRATEGIES China's Distribution Channel To order this report: Chinese Markets for Brain Cancer Treatment Drugs More market research reports here!
Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker Browse other news from this organisation: Reportlinker Source PR Newswire  |
|
Nothing in this website should be used in
place of personal medical advice from your own qualified medical
practitioner. |
All rights reserved. All other trademarks recognized. |
|
